NCT00002137View on ClinicalTrials.gov

A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Sarcoma, KaposiHIV Infections
Interventions
DRUG

Tecogalan sodium

Trial Locations (1)

90033

Kenneth Norris Jr Cancer Ctr / USC, Los Angeles

Sponsors
All Listed Sponsors
lead

Daiichi Pharmaceuticals

INDUSTRY

NCT00002137 - A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4 | Biotech Hunter | Biotech Hunter